Displaying 2721 - 2740 of 5993
Contract Number Brand Code Brand Name Active Ingredient Trade Name Package Size Formulary Category Pkg Price Unit Price Unit Description Max. Reimbursable Quantity / Month Package Description Manufacturer Code Manufacturer Name Agent Code Agent Name Benefit Therapeutic Code Therapeutic Desc Drug Contract Start Date Drug Contract End Date Status Description Default Route Max Repeats Therapeutic Head Amend Date
41 4144V VOLTAREN SR 75MG TAB (NVS) DICLOFENAC SO (C) DICLOFENAC SODIUM VOLTAREN SR 20'S C 27.73 1.3863 TAB 0 BOX NVS NOVARTIS CARIBE SA COL COLLINS LTD 28080492 OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS 2024-04-01 2026-03-31 ORAL 6 OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS
42 4144V VOLTAREN 75MG SR TAB (NVS) DICLOFENAC SODIUM DICLOFENAC SODIUM VOLTAREN 20'S C 27.73 1.39 TAB 28 BLIS NVS NOVARTIS CARIBE SA COL AVENTA BARBADOS 28080492 OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS 2026-04-01 2028-03-31 ORAL 6 OTHER NONSTEROIDAL ANTI-INFLAMMATORY AGENTS
40 41458 ACULAR LS 0.4% EYE DR (ALL/COL) KETOROLAC KETOROLAC ACULAR LS 5ML C 26.64 26.64 EYE DROP 0 BOTT ALL ALLERGAN INTERNATIONAL COL COLLINS LTD 520820 EENT NSAID 2022-04-01 2024-03-31 OPHTHALMIC 0 EYE, EAR, NOSE AND THROAT PREPARATIONS
41 41458 ACULAR LS 0.4% EYE DR (ALL) KETOROLAC (C) KETOROLAC ACULAR LS 5ML C 26.64 26.6396 BOTT 0 BOTT ALL ALLERGAN INTERNATIONAL COL COLLINS LTD 5208 EENT ANTI-INFLAMMATORY AGENTS 2024-04-01 2026-03-31 OPHTHALMIC 0 EENT ANTI-INFLAMMATORY AGENTS
42 41458 ACULAR LS 0.4% EYE DR (ALL) KETOROLAC KETOROLAC ACULAR LS 5ML C 26.64 26.64 BOTT 0 BOTT ALL ALLERGAN INTERNATIONAL COL AVENTA BARBADOS 5208 EENT ANTI-INFLAMMATORY AGENTS 2026-04-01 2028-03-31 OPHTHALMIC 0 EENT ANTI-INFLAMMATORY AGENTS
40 4145AB NEVANAC 0.1% EYE DR (NVS/COL) NEPAFENAC NEPAFENAC NEVANAC 5ML C 16.55 16.55 EYE DROP 0 BOTT NVS NOVARTIS CARIBE SA COL COLLINS LTD 520820 EENT NSAID 2022-04-01 2024-03-31 OPHTHALMIC 0 EYE, EAR, NOSE AND THROAT PREPARATIONS
41 4145AB NEVANAC 0.1% EYE DR (NVS) NEPAFENAC (C) NEPAFENAC NEVANAC 5ML C 16.55 16.5546 BOTT 1 BOTT NVS NOVARTIS CARIBE SA COL COLLINS LTD 520892 EENT ANTI INFLAMMATORY AGENTS MISCELLANEOUS 2024-04-01 2026-03-31 OPHTHALMIC 3 EENT ANTI INFLAMMATORY AGENTS MISCELLANEOUS
42 4145AB NEVANAC 0.1% EYE DR (NVS) NEPAFENAC NEPAFENAC NEVANAC 5ML C 16.55 16.55 BOTT 1 BOTT NVS NOVARTIS CARIBE SA COL AVENTA BARBADOS 520892 EENT ANTI INFLAMMATORY AGENTS MISCELLANEOUS 2026-04-01 2028-03-31 OPHTHALMIC 3 EENT ANTI INFLAMMATORY AGENTS MISCELLANEOUS
40 4145AE NEPAFENAC 0.1% EYE DR (CIR/AHI) NEPAFENAC NEPAFENAC 5ML A 7.48 7.48 EYE DROP 1 BOTT CIR CIRON PHARMA AHI ARMSTRONG HEALTHCARE INC 520820 EENT NSAID 2022-04-01 2024-03-31 OPHTHALMIC 3 EYE, EAR, NOSE AND THROAT PREPARATIONS
40 4145AF DICLOFENAC SOD 0.1% EYE DR (FSB/ATB) DICLOFEN DICLOFENAC SODIUM DICLOFENAC SOD 5ML A 5.30 5.30 EYE DROP 1 BOTT FSB FLAGSHIP BIOTECH ATB ANSA TRADING BARBADOS LTD 520892 EENT ANTI INFLAMMATORY AGENTS MISCELLANEOUS 2022-04-01 2024-03-31 OPHTHALMIC 6 EYE, EAR, NOSE AND THROAT PREPARATIONS
41 4145AF DICLOFENAC SODIUM 0.1% EYE DR (FSB) DICLOFENAC SODIUM DICLOFENAC SODIUM 5ML A 3.04 3.0445 BOTT 1 BOTT FSB FLAGSHIP BIOTECH ATB ANSA TRADING BARBADOS LTD 520892 EENT ANTI INFLAMMATORY AGENTS MISCELLANEOUS 2024-04-01 2026-03-31 OPHTHALMIC 6 EENT ANTI INFLAMMATORY AGENTS MISCELLANEOUS
41 4145AG NEPATOP FREE 0.1% EYE DR (SYP) NEPAFENAC NEPAFENAC NEPATOP FREE 5ML A 8.92 8.9161 BOTT 1 BOTT SYP SYAASH PHARMACEUTICALS PSB PHARMACEUTICAL SOLUTIONS BARBA 5208 EENT ANTI-INFLAMMATORY AGENTS 2024-04-01 2026-03-31 OPHTHALMIC 3 EENT ANTI-INFLAMMATORY AGENTS
42 4145AG NEPATOP FREE 0.1% EYE DR (SYP) NEPAFENAC NEPAFENAC NEPATOP FREE 5ML A 9.11 9.11 BOTT 1 BOTT SYP SYAASH PHARMACEUTICALS PSB PHARMACEUTICAL SOLUTIONS BARBA 5208 EENT ANTI-INFLAMMATORY AGENTS 2026-04-01 2028-03-31 OPHTHALMIC 3 EENT ANTI-INFLAMMATORY AGENTS
42 4145AJ DICLOFENAC SODIUM 0.1% EYE DR (FSB) DICLOFENAC SODIUM DICLOFENAC SODIUM 5ML A 2.75 2.75 BOTT 1 FSB FLAGSHIP BIOTECH STO BRYDEN STOKES LTD 520892 EENT ANTI INFLAMMATORY AGENTS MISCELLANEOUS 2026-04-01 2028-03-31 OPHTHALMIC 6 EENT ANTI INFLAMMATORY AGENTS MISCELLANEOUS 2026-03-05
40 41514 PARLODEL 2.5MG TAB (BCH/COL) BROMOCRIPTINE BROMOCRIPTINE PARLODEL 30'S C 19.90 0.66 TABLET 0 TAB BCH SANDOZ COL COLLINS LTD 283620 DOPAMINE RECEPTOR AGONIST 2022-04-01 2024-03-31 Oral 0 CENTRAL NERVOUS SYSTEM DRUGS
40 41519 AAP-BROMOCRIPTINE 2.5MG TAB (APO/COL) BROMOCRIPTINE AAP-BROMOCRIPTINE 100'S C 44.28 0.44 TABLET 0 TAB APO APOTEX INC. COL COLLINS LTD 283620 DOPAMINE RECEPTOR AGONIST 2022-04-01 2024-03-31 Name Change Oral 0 CENTRAL NERVOUS SYSTEM DRUGS 2022-04-04
42 41519 AAP-BROMOCRIPTINE 2.5MG TAB (APO) BROMOCRIPTINE AAP-BROMOCRIPTINE 100'S A 45.18 0.45 TAB 90 BOTT APO APOTEX INC. COL AVENTA BARBADOS 283620 DOPAMINE RECEPTOR AGONIST 2026-04-01 2028-03-31 ORAL 6 DOPAMINE RECEPTOR AGONIST
40 4151H BROMOCRIPTINE 2.5MG TAB (KWA/ATB) BROMOCRIPTINE BROMOCRIPTINE 10X10 A 8.56 0.29 TABLET 90 TAB KWA KWALITY PHARMACEUTICALS ATB ANSA TRADING BARBADOS LTD 283620 DOPAMINE RECEPTOR AGONIST 2022-04-01 2024-03-31 Oral 6 CENTRAL NERVOUS SYSTEM DRUGS
41 4151J AAP-BROMOCRIPTINE 2.5MG TAB (APO) (C) BROMOCRIPTINE AAP-BROMOCRIPTINE 100'S C 45.18 0.4518 TAB 90 BOTT APO APOTEX INC. ATB ANSA TRADING BARBADOS LTD 283620 DOPAMINE RECEPTOR AGONIST 2024-04-01 2026-03-31 ORAL 6 DOPAMINE RECEPTOR AGONIST
41 4151K BROMOCRIPTINE 2.5MG TAB (KWA) BROMOCRIPTINE BROMOCRIPTINE 30'S A 8.32 0.2773 TAB 90 BOX KWA KWALITY PHARMACEUTICALS ATB ANSA TRADING BARBADOS LTD 283620 DOPAMINE RECEPTOR AGONIST 2024-04-01 2026-03-31 ORAL 6 DOPAMINE RECEPTOR AGONIST